Street, Chris
June 2000
Joe Weider's Muscle & Fitness;Jun2000, Vol. 61 Issue 6, p138
Discusses the physiological effect of taking ephedrine-caffeine-aspirin (ECA) stack. Use of ephedrine and caffeine in weight loss program; Results of studies; Effects of the ECA stack on thermogenesis; Safety precautions in using the stack. INSETS: Three's Company? The Quest for the Missing..., by Brian Rowley;Major Players;Common Side Effects of the ECA Stack.


Related Articles

  • Weight Loss.  // Women's Health;Jan/Feb2011, Vol. 8 Issue 1, p26 

    This section offers news briefs related to weight loss. A study found that women who take prescription antihistamines are 10 pounds heavier than those who do not take the drugs. Researchers have reported that they have found that exercise reduces inflammation in the hypothalamus of obese rodents...

  • Rimonabant's benefits 'unclear'.  // Pulse;2/1/2007, Vol. 67 Issue 4, p15 

    The article reports on the issue regarding the effectivity of Rimonabant, a new drug developed to regulate obesity in Great Britain. The findings of the review conducted for the said drug demonstrates the ambiguity of its benefits in obesity management. The National Prescribing Centre has been...

  • Weight loss dynamics during combined fluoxetine and olanzapine treatment. Perrone, Jennifer A.; Chabla, Janet M.; Hallas, Brian H.; Horowitz, Judith M.; Torres, German // BMC Pharmacology;2004, Vol. 4, p27 

    Background: Fluoxetine and olanzapine combination therapy is rapidly becoming an effective strategy for managing symptoms of treatment-resistant depression. Determining drug-drug interactions, drug metabolism and pharmacokinetics is of particular interest for revealing potential liabilities...

  • Heart drugs under study focus on impact on metabolism. Alexander, Walter // Drug Topics;12/13/2004, Vol. 148 Issue 23, THE HEALTH-SYSTEM PHARMACIST p8 

    This article focuses on the benefits of the drug rimonabant, presented at the 2004 Scientific Sessions of the American Heart Association held in New Orleans, Louisiana. Results with rimonabant, a selective cannabinoid type-1 receptor blocker, have been promising, demonstrating significant weight...

  • Weight-loss Drug Effective Without Cardiac Side Effects?  // OB/GYN Clinical Alert;Sep2010 Pharmacology, p1 

    The article presents a company-sponsored study published in the "New England Journal of Medicine" which validates the efficacy of weight-loss drug in the U.S. The phase III trial of the study was conducted with 3,180 patients who received 10 milligrams of lorcaserin or placebo twice daily. The...

  • better health. quick change. Tweed, Vera // Better Nutrition;Apr2013, Vol. 75 Issue 4, p22 

    The article presents information about the weight loss dietary supplement Garcinia cambogia, a tamarind fruit from India which inhibits the conversion of dietary sugars and carbohydrates into body fat, reduces appetite, and controls blood sugar and cholesterol. The fruit contains hydroxycitric...

  • Rimonabant: From RIO to Ban. Sam, Amir H.; Salem, Victoria; Ghatei, Mohammad A. // Journal of Obesity;2011, Vol. 2011, Special section p1 

    Endocannabinoid antagonism as a treatment for obesity and the metabolic syndrome became a hugely anticipated area of pharmacology at the start of the century. The CB1 receptor antagonist Rimonabant entered the European mass market on the back of several trials showing weight loss benefits...

  • DRUG OF THE MONTH: Zantrex-3. Casey, Susan // Esquire;Feb2005, Vol. 143 Issue 2, p62 

    Features the diet pill Zantrex-3. Ingredients of the product; Side effects caused by the drug; Suggestions for losing weight the natural way.

  • sibutramine.  // Davis's Drug Guide for Nurses, 10th edition;2007, p1073 

    The article provides information on sibutramine, an appetite suppressant or weight control agent used in the treatment of obesity. The drug decreases hunger with resultant weight loss in obese patients. Some of the drug's adverse reactions or side effects include seizures, laryngitis,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics